Royalty Pharma EVP Christopher Hite disposes of 100,000 common shares worth $5,853,719.88
Bitget2026/09/24 20:11- Royalty Pharma EVP and Chairman, Partnering Christopher Hite sold 100,000 Class A ordinary shares on Sep. 22.
- Sales executed through SCH Investment Partners, reducing its stake to 270,401 shares; Hite still held 23,200 shares directly.
- Disposals priced at USD 58.5148 and USD 58.9261 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
